Is Amrutanjan Health Care a Good Buy After Its Q1 FY27 Results?

The Amrutanjan Health Care share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Amrutanjan Health Care is a consumer healthcare company known for pain-relief balms, expanding into women's hygiene products, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 103 crore, up 9.5% year on year, while profit after tax came in at Rs 4.37 crore, down 47.4% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Amrutanjan Health Care share price from here.

This piece works through the quarter's financial highlights, the business factors behind the numbers, where the Amrutanjan Health Care share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Amrutanjan Health Care Q1 FY27 Financial Highlights

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 103 crore	Rs 94 crore	9.5%
Operating Margin	6.1%	9.0%	NA
Profit Before Tax	Rs 8.10 crore	Rs 11 crore	-28.3%
Net Profit / (Loss)	Rs 4.37 crore	Rs 8.31 crore	-47.4%

Amrutanjan Health Care Q1 FY27 Performance Analysis

Check Amrutanjan Health Care Fundamentals on Univest Screener

Revenue growth of 9.5% for the quarter came from steady demand across the company's core business, keeping the topline trend intact for the consumer healthcare and pain-relief products sector.

Profitability is where the quarter disappointed. PAT fell 47% year on year to Rs 4.37 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Amrutanjan Health Care share price this quarter.

Sequential quarterly data was not fully available for this comparison, so investors should track the next quarter's results to build out the trend behind the Amrutanjan Health Care share price.

Key Business Factors in Q1 FY27

Revenue Trend

Amrutanjan Health Care's revenue grew 9.5% year on year this quarter, taking the quarterly base to Rs 103 crore in a consumer healthcare and pain-relief products business that remains sensitive to demand and pricing cycles that ultimately feed through to the Amrutanjan Health Care share price.

Profitability Trend

Profit before tax came in at Rs 8.10 crore for the quarter, against Rs 11 crore a year earlier, a figure worth tracking alongside the headline PAT number for a fuller picture of the quarter.

Balance Sheet Position

Amrutanjan Health Care's balance sheet metrics were not fully available for this quarter and should be checked against the company's official filings before making an investment decision.

Valuation Context

Amrutanjan Health Care does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Amrutanjan Health Care share price.

Dividend Details

No interim dividend was declared alongside Amrutanjan Health Care's Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Amrutanjan Health Care share price for income should watch the company's announcements around its next annual results for any dividend decision.

Amrutanjan Health Care Share Price Outlook for FY27

The key question for the rest of FY27 is whether Amrutanjan Health Care can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Amrutanjan Health Care share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.

A stabilising or improving margin trend in the next result would be the clearest signal that this quarter's profit decline was a temporary setback rather than the start of a longer slide for the Amrutanjan Health Care share price.

Amrutanjan Health Care Stock Performance

Download the Univest iOS App or Univest Android App to track Amrutanjan Health Care's live share price and get daily stock updates.

The Amrutanjan Health Care share price was trading around Rs 496 as results season played out in late August 2026, roughly 37.3% below its 52-week high of Rs 791 and hovering just above its 52-week low of Rs 483.

The Amrutanjan Health Care share price has likely already absorbed some of this quarter's disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off.

Key Risks

Profitability Risk

The quarter's profit trend is the clearest risk here. Until Amrutanjan Health Care shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.

Sector and Demand Risk

As a consumer healthcare and pain-relief products business, Amrutanjan Health Care's results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Amrutanjan Health Care share price well before the next result.

Execution Risk

Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

Conclusion

Amrutanjan Health Care's Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 47% to Rs 4.37 crore even as revenue rose. The Amrutanjan Health Care share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter's numbers until the margin trend turns around.

Frequently Asked Questions on Amrutanjan Health Care Q1 FY27 Results

What were Amrutanjan Health Care's Q1 FY27 results?

Ans. Amrutanjan Health Care reported Q1 FY27 revenue of Rs 103 crore, up 9.5% year on year, and PAT of Rs 4.37 crore, down 47.4% year on year.

Is Amrutanjan Health Care a good buy after its Q1 FY27 results?

Ans. Amrutanjan Health Care's profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.

What is the Amrutanjan Health Care share price today?

Ans. The Amrutanjan Health Care share price was trading around Rs 496 in late August 2026, about 37.3% below its 52-week high of Rs 791 and well above its 52-week low of Rs 483.

What is Amrutanjan Health Care's revenue and profit for Q1 FY27?

Ans. Amrutanjan Health Care reported revenue of Rs 103 crore and a net profit of Rs 4.37 crore for the quarter ended June 30, 2026.

Did Amrutanjan Health Care declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Amrutanjan Health Care's Q1 FY27 results. Investors should track the company's next annual results for any dividend announcement.

What is Amrutanjan Health Care's PE ratio and is it expensive?

Ans. The Amrutanjan Health Care share price trades at a trailing PE of 26.8x. Investors should compare this with the company's growth rate before judging value.

What are the key risks for Amrutanjan Health Care investors right now?

Ans. The quarter's profit trend is the clearest risk here. Until Amrutanjan Health Care shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

What is Amrutanjan Health Care's promoter shareholding?

Ans. Promoter shareholding data for Amrutanjan Health Care was not fully available for this quarter and should be checked on the company's official filings.